The global market for Gene Synthesis was valued at US$ 669 million in the year 2024 and is projected to reach a revised size of US$ 1905 million by 2031, growing at a CAGR of 16.4% during the forecast period.
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
The gene synthesis market is experiencing robust growth, propelled by advancements in synthetic biology, personalized medicine, and biopharmaceutical development. Technological innovations such as CRISPR-based gene editing, automation, and high-throughput sequencing have streamlined the synthesis process, making it more efficient and cost-effective. These developments have expanded the applications of gene synthesis across various sectors, including healthcare, agriculture, and industrial biotechnology. In healthcare, for instance, gene synthesis is instrumental in developing targeted therapies and vaccines, while in agriculture, it aids in creating genetically modified crops with improved traits. The integration of artificial intelligence and machine learning further enhances the design and optimization of synthetic genes, accelerating research and development efforts.
Regionally, North America holds a significant share of the gene synthesis market, driven by substantial investments in research and development, a strong presence of key industry players, and supportive government policies. Asia-Pacific is emerging as a rapidly growing market, with countries like China and India investing heavily in biotechnology and synthetic biology initiatives. Despite the promising growth, the market faces challenges such as ethical concerns, regulatory hurdles, and the high cost of gene synthesis technologies. Addressing these issues through transparent policies, public engagement, and continued technological advancements will be crucial for the sustained expansion of the gene synthesis market.
This report aims to provide a comprehensive presentation of the global market for Gene Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Synthesis.
The Gene Synthesis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Synthesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Synthesis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genescript
Thermo Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Segment by Type
Below 1000 bp
1001-3000 bp
3001-5000 bp
Above 5000 bp
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Synthesis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Below 1000 bp
1.2.3 1001-3000 bp
1.2.4 3001-5000 bp
1.2.5 Above 5000 bp
1.3 Market by Application
1.3.1 Global Gene Synthesis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Synthesis Market Perspective (2020-2031)
2.2 Global Gene Synthesis Growth Trends by Region
2.2.1 Global Gene Synthesis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Synthesis Historic Market Size by Region (2020-2025)
2.2.3 Gene Synthesis Forecasted Market Size by Region (2026-2031)
2.3 Gene Synthesis Market Dynamics
2.3.1 Gene Synthesis Industry Trends
2.3.2 Gene Synthesis Market Drivers
2.3.3 Gene Synthesis Market Challenges
2.3.4 Gene Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Synthesis Players by Revenue
3.1.1 Global Top Gene Synthesis Players by Revenue (2020-2025)
3.1.2 Global Gene Synthesis Revenue Market Share by Players (2020-2025)
3.2 Global Top Gene Synthesis Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Synthesis Revenue
3.4 Global Gene Synthesis Market Concentration Ratio
3.4.1 Global Gene Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Synthesis Revenue in 2024
3.5 Global Key Players of Gene Synthesis Head office and Area Served
3.6 Global Key Players of Gene Synthesis, Product and Application
3.7 Global Key Players of Gene Synthesis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Synthesis Breakdown Data by Type
4.1 Global Gene Synthesis Historic Market Size by Type (2020-2025)
4.2 Global Gene Synthesis Forecasted Market Size by Type (2026-2031)
5 Gene Synthesis Breakdown Data by Application
5.1 Global Gene Synthesis Historic Market Size by Application (2020-2025)
5.2 Global Gene Synthesis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Synthesis Market Size (2020-2031)
6.2 North America Gene Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Synthesis Market Size by Country (2020-2025)
6.4 North America Gene Synthesis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Synthesis Market Size (2020-2031)
7.2 Europe Gene Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Synthesis Market Size by Country (2020-2025)
7.4 Europe Gene Synthesis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Synthesis Market Size (2020-2031)
8.2 Asia-Pacific Gene Synthesis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Synthesis Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Synthesis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Synthesis Market Size (2020-2031)
9.2 Latin America Gene Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Synthesis Market Size by Country (2020-2025)
9.4 Latin America Gene Synthesis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Synthesis Market Size (2020-2031)
10.2 Middle East & Africa Gene Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Synthesis Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Synthesis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genescript
11.1.1 Genescript Company Details
11.1.2 Genescript Business Overview
11.1.3 Genescript Gene Synthesis Introduction
11.1.4 Genescript Revenue in Gene Synthesis Business (2020-2025)
11.1.5 Genescript Recent Development
11.2 Thermo Scientific
11.2.1 Thermo Scientific Company Details
11.2.2 Thermo Scientific Business Overview
11.2.3 Thermo Scientific Gene Synthesis Introduction
11.2.4 Thermo Scientific Revenue in Gene Synthesis Business (2020-2025)
11.2.5 Thermo Scientific Recent Development
11.3 IDT
11.3.1 IDT Company Details
11.3.2 IDT Business Overview
11.3.3 IDT Gene Synthesis Introduction
11.3.4 IDT Revenue in Gene Synthesis Business (2020-2025)
11.3.5 IDT Recent Development
11.4 Eurofins Genomics
11.4.1 Eurofins Genomics Company Details
11.4.2 Eurofins Genomics Business Overview
11.4.3 Eurofins Genomics Gene Synthesis Introduction
11.4.4 Eurofins Genomics Revenue in Gene Synthesis Business (2020-2025)
11.4.5 Eurofins Genomics Recent Development
11.5 DNA 2.0 (ATUM)
11.5.1 DNA 2.0 (ATUM) Company Details
11.5.2 DNA 2.0 (ATUM) Business Overview
11.5.3 DNA 2.0 (ATUM) Gene Synthesis Introduction
11.5.4 DNA 2.0 (ATUM) Revenue in Gene Synthesis Business (2020-2025)
11.5.5 DNA 2.0 (ATUM) Recent Development
11.6 BBI
11.6.1 BBI Company Details
11.6.2 BBI Business Overview
11.6.3 BBI Gene Synthesis Introduction
11.6.4 BBI Revenue in Gene Synthesis Business (2020-2025)
11.6.5 BBI Recent Development
11.7 Azenta Life Sciences
11.7.1 Azenta Life Sciences Company Details
11.7.2 Azenta Life Sciences Business Overview
11.7.3 Azenta Life Sciences Gene Synthesis Introduction
11.7.4 Azenta Life Sciences Revenue in Gene Synthesis Business (2020-2025)
11.7.5 Azenta Life Sciences Recent Development
11.8 SBS Genetech
11.8.1 SBS Genetech Company Details
11.8.2 SBS Genetech Business Overview
11.8.3 SBS Genetech Gene Synthesis Introduction
11.8.4 SBS Genetech Revenue in Gene Synthesis Business (2020-2025)
11.8.5 SBS Genetech Recent Development
11.9 Bio Basic
11.9.1 Bio Basic Company Details
11.9.2 Bio Basic Business Overview
11.9.3 Bio Basic Gene Synthesis Introduction
11.9.4 Bio Basic Revenue in Gene Synthesis Business (2020-2025)
11.9.5 Bio Basic Recent Development
11.10 Twist Bioscience
11.10.1 Twist Bioscience Company Details
11.10.2 Twist Bioscience Business Overview
11.10.3 Twist Bioscience Gene Synthesis Introduction
11.10.4 Twist Bioscience Revenue in Gene Synthesis Business (2020-2025)
11.10.5 Twist Bioscience Recent Development
11.11 OriGene
11.11.1 OriGene Company Details
11.11.2 OriGene Business Overview
11.11.3 OriGene Gene Synthesis Introduction
11.11.4 OriGene Revenue in Gene Synthesis Business (2020-2025)
11.11.5 OriGene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Genescript
Thermo Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
听
听
*If Applicable.
